Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, posted on X:
“List of adjuvant immunotherapy trials in resected RCC. Only KN 564 shwed OS, Trials with nivo, nivo-ipi and atezo were a failure. Results of RAMPART with adjuvant durvalumab/durva-tremi are pending!”
